.50 semaglutide Injection 0.50 mg/0.5 ml Medicare GLP-1 Bridge: New 50

Today, we unpack Marty Makarys Senate confirmation hearing, see a new ruling against GLP-1 compounders, examine the effects of the NIH patent freeze, and explore the tumultuous biotech job market

Even though GLP-1 RAs mimic a natural hormone in the body, they do have some potential GI side effects, including constipation, which appears to be more common than diarrhea in patients who reach out to Oshi Health for help

GLP-1 (glucagon-like peptide-1) receptor agonists have gained popularity as an effective treatment for weight loss and diabetes management

Role of GFAP in CNS injuries

Patients commonly report symptoms at their usual threshold, despite a later gas rise